Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizuma
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis...
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizuma
Pre‐treatment magnetic resonance enterography findings predict the response to TNF‐alpha inhibitors
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentration
A Post Hoc Analysis of the PAILOT Randomized Controlled Trial
Combination Therapy of Adalimumab With an Immunomodulator
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID
Adaptations to the British Society of Gastroenterology guidelines
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B